LGNDNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as LGNDZ, LGNXZ, LGNYZ, LGNZZ
LIGAND PHARMACEUTICALS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$297.28+1.74 (+0.59%)
Close on Oct 19, 2026
- Market cap
- $6.49B
- P/E (TTM)
- 31.6
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
23M
Shares held, 13F filers
Institutional holders
415
97 new, 34 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 125 sales
Net sold $33.21M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Vanguard Capital Management | 997,637 | 5.00% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 2,839,251 | 14.50% | 13G (passive) amendment | Sep 30, 2025 |
| Invesco Ltd. | 1,218,846 | 6.10% | 13G (passive) | Jun 30, 2026 |
| Vanguard Portfolio Management | 1,109,154 | 5.56% | 13G (passive) | Mar 31, 2026 |
| Janus Henderson Group PLC | 1,042,378 | 5.30% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LGND | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,100,996 | – | $980.19M | +139,073 | 0.01% |
| Invesco Ltd. | 1,201,644 | – | $379.83M | +378,040 | 0.03% |
| Vanguard Portfolio Management LLC | 1,138,316 | – | $359.81M | +38,049 | 0.02% |
| Jupiter Topco LLC | 1,040,578 | – | $328.91M | New | 0.13% |
| Vanguard Capital Management LLC | 870,950 | – | $275.30M | +22,861 | 0.01% |
| State Street Corp | 826,539 | – | $261.25M | +47,683 | 0.01% |
| FMR LLC | 762,827 | – | $241.12M | +166,700 | 0.01% |
| Franklin Resources Inc | 752,044 | – | $237.71M | +178,867 | 0.05% |
| Congress Asset Management Co /Ma | 659,911 | – | $208.59M | +155,274 | 1.28% |
| Geode Capital Management, LLC | 589,020 | – | $186.21M | +30,086 | 0.01% |
| Nomura Asset Management International Inc. | 568,371 | – | $179.66M | −4,941 | 0.27% |
| Chicago Capital, LLC | 553,435 | – | $174.94M | −8,240 | 4.21% |
| Stephens Investment Management Group LLC | 475,609 | – | $150.34M | −19,061 | 1.61% |
| Dimensional Fund Advisors LP | 429,314 | – | $135.70M | +4,084 | 0.02% |
| Massachusetts Financial Services Co /Ma/ | 375,762 | – | $118.77M | −35,781 | 0.04% |
| Goldman Sachs Group Inc | 323,245 | – | $102.17M | −57,866 | 0.01% |
| Loomis Sayles & Co L P | 291,805 | – | $92.24M | −61,404 | 0.12% |
| Rice Hall James & Associates, LLC | 270,052 | – | $85.36M | −13,515 | 4.15% |
| Ranger Investment Management, L.P. | 257,596 | – | $81.42M | −10,347 | 5.15% |
| Northern Trust Corp | 257,389 | – | $81.36M | +3,231 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 415 | 23M | 97 / 149 | 114 / 34 | 4M | 1M |
| Q1 2026 | 359 | 21M | 59 / 133 | 115 / 43 | 3M | 1M |
| Q4 2025 | 350 | 21M | 70 / 110 | 116 / 30 | 2M | 2M |
| Q3 2025 | 314 | 21M | 64 / 100 | 103 / 16 | 3M | 1M |
| Q2 2025 | 271 | 19M | 33 / 110 | 88 / 23 | 1M | 1M |
| Q1 2025 | 262 | 19M | 33 / 102 | 86 / 27 | 1M | 1M |
| Q4 2024 | 258 | 18M | 41 / 108 | 62 / 22 | 1M | 1M |
| Q3 2024 | 243 | 18M | 38 / 97 | 53 / 28 | 4M | 1M |
| Q2 2024 | 235 | 17M | 43 / 82 | 73 / 27 | 2M | 2M |
| Q1 2024 | 222 | 17M | 33 / 64 | 71 / 19 | 2M | 1M |
| Q4 2023 | 211 | 16M | 34 / 72 | 71 / 17 | 1M | 1M |
| Q3 2023 | 196 | 16M | 20 / 67 | 77 / 27 | 1M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of LGND | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 1,207,351 | – | $381.63M | 0.34% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 605,720 | – | $191.46M | 0.01% | Jun 30, 2026 |
| Franklin Dynatech Fund | 550,000 | – | $173.85M | 0.58% | Jun 30, 2026 |
| Invesco Discovery Fund | 519,159 | – | $120.42M | 1.54% | May 31, 2026 |
| iShares Russell 2000 ETF | 515,565 | – | $162.96M | 0.20% | Jun 30, 2026 |
| Janus Henderson Triton Fund | 494,252 | – | $156.23M | 2.63% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 436,817 | – | $138.07M | 0.07% | Jun 30, 2026 |
| Nomura Small Cap Core Fund | 385,274 | – | $89.37M | 1.62% | May 29, 2026 |
| Fidelity Small Cap Value Fund | 325,665 | – | $93.64M | 1.71% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 276,594 | – | $87.43M | 0.13% | Jun 30, 2026 |
| Janus Henderson Venture Fund | 275,579 | – | $87.11M | 2.41% | Jun 30, 2026 |
| Congress Small Cap Growth Fund | 271,577 | – | $78.09M | 3.89% | Jul 31, 2026 |
| Vanguard Explorer Fund | 234,250 | – | $67.36M | 0.30% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 229,869 | – | $72.66M | 0.07% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 219,513 | – | $63.12M | 0.19% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Todd C. Davis | Chief Executive Officer, Director | 199,513 | Jul 6, 2026 |
| Andrew Reardon | CLO & Secretary | 36,514 | Sep 8, 2026 |
| Octavio Espinoza | Chief Financial Officer | 48,818 | Aug 14, 2026 |
| Martine Zimmermann | Director | 3,782 | Sep 24, 2026 |
| Jason Haas | Director | 3,981 | Aug 14, 2026 |
| Stephen L. Sabba | Director | 33,629 | Jun 18, 2026 |
| John L. Lamattina | Director | 31,071 | Jun 12, 2026 |
| Jason Aryeh | Director | 115,580 | Jun 12, 2026 |
| John W. Kozarich | Director | 42,622 | Jun 9, 2026 |
| Nancy Ryan Gray | Director | 8,930 | Jun 9, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Martine Zimmermann Director | Sep 22, 2026 | Tax withholding | −115 | $298.50 | $34.33K | 3,782 |
| Martine Zimmermann Director | Sep 10, 2026 | Sale | −1,200 | $285.00 | $342.00K | 3,897 |
| Andrew Reardon CLO & Secretary | Sep 3, 2026 | Sale(10b5-1 plan) | −400 | $288.98 | $115.59K | 36,514 |
| Andrew Reardon CLO & Secretary | Sep 3, 2026 | Sale(10b5-1 plan) | −300 | $283.99 | $85.20K | 41,214 |
| Andrew Reardon CLO & Secretary | Sep 3, 2026 | Sale(10b5-1 plan) | −2,115 | $286.36 | $605.65K | 37,299 |
| Andrew Reardon CLO & Secretary | Sep 3, 2026 | Sale(10b5-1 plan) | −1,800 | $285.17 | $513.31K | 39,414 |
| Andrew Reardon CLO & Secretary | Sep 3, 2026 | Sale(10b5-1 plan) | −385 | $287.53 | $110.70K | 36,914 |
| Jason Haas Director | Aug 12, 2026 | Sale | −7,138 | $292.81 | $2.09M | 3,981 |
| Jason Haas Director | Aug 12, 2026 | Option exercise | +6,138 | $51.56 | $316.48K | 11,119 |
| Octavio Espinoza Chief Financial Officer | Aug 12, 2026 | Option exercise | +2,869 | $55.75 | $159.95K | 48,818 |
| Octavio Espinoza Chief Financial Officer | Aug 12, 2026 | Option exercise | +2,074 | $70.04 | $145.26K | 45,949 |
| Octavio Espinoza Chief Financial Officer | Aug 12, 2026 | Sale(10b5-1 plan) | −31,641 | $292.07 | $9.24M | 27,696 |
| Octavio Espinoza Chief Financial Officer | Aug 12, 2026 | Option exercise | +7,171 | $57.22 | $410.32K | 55,989 |
| Octavio Espinoza Chief Financial Officer | Aug 12, 2026 | Option exercise | +3,348 | $68.74 | $230.14K | 59,337 |
| Octavio Espinoza Chief Financial Officer | Aug 12, 2026 | Option exercise | +16,179 | $52.84 | $854.90K | 43,875 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −503 | $289.80 | $145.77K | 43,114 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −356 | $288.75 | $102.80K | 43,617 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −1,214 | $287.77 | $349.35K | 43,973 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −1,032 | $286.80 | $295.98K | 45,187 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −157 | $285.74 | $44.86K | 46,219 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −33 | $284.55 | $9.39K | 46,376 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −105 | $284.14 | $29.83K | 46,409 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Option exercise | +5,000 | $52.27 | $261.35K | 46,514 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −409 | $292.82 | $119.76K | 41,514 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −991 | $291.71 | $289.08K | 41,923 |
| Andrew Reardon CLO & Secretary | Aug 3, 2026 | Sale(10b5-1 plan) | −200 | $290.60 | $58.12K | 42,914 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Option exercise | +5,000 | $52.27 | $261.35K | 46,514 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Sale(10b5-1 plan) | −396 | $308.99 | $122.36K | 46,118 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Sale(10b5-1 plan) | −104 | $310.20 | $32.26K | 46,014 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Sale(10b5-1 plan) | −1,119 | $311.72 | $348.81K | 44,895 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Sale(10b5-1 plan) | −1,081 | $312.28 | $337.57K | 43,814 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Sale(10b5-1 plan) | −700 | $313.46 | $219.42K | 43,114 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Sale(10b5-1 plan) | −100 | $314.58 | $31.46K | 43,014 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Sale(10b5-1 plan) | −900 | $315.78 | $284.20K | 42,114 |
| Andrew Reardon CLO & Secretary | Jul 1, 2026 | Sale(10b5-1 plan) | −600 | $317.15 | $190.29K | 41,514 |
| Octavio Espinoza Chief Financial Officer | Jun 30, 2026 | Other | +17 | $160.71 | $2.73K | 27,696 |
| Todd C. Davis Chief Executive Officer, Director | Jun 30, 2026 | Other | +132 | $160.71 | $21.21K | 199,513 |
| Andrew Reardon CLO & Secretary | Jun 30, 2026 | Other | +132 | $160.71 | $21.21K | 41,514 |
| Stephen L. Sabba Director | Jun 16, 2026 | Sale | −2,145 | $254.00 | $544.83K | 33,629 |
| Stephen L. Sabba Director | Jun 16, 2026 | Option exercise | +2,145 | $66.13 | $141.85K | 35,774 |
| Jason Haas Director | Jun 12, 2026 | Option exercise | +1,000 | $51.56 | $51.56K | 11,442 |
| Jason Haas Director | Jun 12, 2026 | Sale | −3,000 | $255.01 | $765.03K | 8,442 |
| Jason Haas Director | Jun 12, 2026 | Sale | −3,461 | $256.08 | $886.29K | 4,981 |
| Jason Haas Director | Jun 12, 2026 | Option exercise | +3,000 | $51.56 | $154.68K | 10,442 |
| Jason Aryeh Director | Jun 11, 2026 | Sale | −4,500 | $250.00 | $1.13M | 102,580 |
| John L. Lamattina Director | Jun 10, 2026 | Sale | −232 | $248.11 | $57.56K | 31,071 |
| John L. Lamattina Director | Jun 10, 2026 | Sale | −697 | $249.53 | $173.92K | 30,374 |
| John L. Lamattina Director | Jun 10, 2026 | Sale | −3,405 | $251.62 | $856.77K | 26,969 |
| John L. Lamattina Director | Jun 10, 2026 | Sale | −257 | $247.22 | $63.54K | 31,303 |
| Jason Aryeh Director | Jun 10, 2026 | Sale | −500 | $250.00 | $125.00K | 107,080 |
| Jason Aryeh Director | Jun 5, 2026 | Award | +836 | – | – | 107,580 |
| Jason Haas Director | Jun 5, 2026 | Award | +836 | – | – | 7,442 |
| John L. Lamattina Director | Jun 5, 2026 | Award | +836 | – | – | 31,560 |
| Stephen L. Sabba Director | Jun 5, 2026 | Award | +836 | – | – | 33,629 |
| Nancy Ryan Gray Director | Jun 5, 2026 | Award | +836 | – | – | 8,930 |
| John W. Kozarich Director | Jun 5, 2026 | Award | +836 | – | – | 42,622 |
| Martine Zimmermann Director | Jun 5, 2026 | Tax withholding | −182 | $237.00 | $43.13K | 5,097 |
| Martine Zimmermann Director | Jun 5, 2026 | Award | +836 | – | – | 5,279 |
| Andrew Reardon CLO & Secretary | Jun 1, 2026 | Sale(10b5-1 plan) | −1,216 | $229.47 | $279.04K | 41,582 |
| Andrew Reardon CLO & Secretary | Jun 1, 2026 | Sale(10b5-1 plan) | −200 | $230.41 | $46.08K | 41,382 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Zimmermann Martine Director | Sep 10, 2026 | 1,200 | $342.00K | Sep 10, 2026 | Restricted Stock |
| Reardon Andrew Officer | Sep 3, 2026 | 15,000 | $4.30M | Sep 3, 2026 | Exercise of Stock Options |
| Espinoza Octavio Officer | Aug 12, 2026 | 31,641 | $9.14M | Aug 12, 2026 | Exercise of Stock Options |
| Haas Jason Director | Aug 12, 2026 | 7,138 | $2.09M | Aug 12, 2026 | Stock Option Exercise |
| Reardon Andrew Officer | Jul 1, 2026 | 10,000 | $3.16M | Jul 1, 2026 | Exercise of Stock Options |
| L. Sabba Stephen Director | Jun 16, 2026 | 2,145 | $544.83K | Jun 16, 2026 | Stock Option Exercise |
| Haas Jason Director | Jun 12, 2026 | 6,461 | $1.65M | Jun 12, 2026 | Stock Option Exercise |
| Jason Aryeh Director | Jun 11, 2026 | 4,500 | $1.12M | Jun 11, 2026 | Open Market Purchase |
| Jason Aryeh Director | Jun 10, 2026 | 5,000 | $1.25M | Jun 10, 2026 | Open Market Purchases |
| L. Lamattina John Director | Jun 10, 2026 | 4,519 | $1.13M | Jun 10, 2026 | Restricted Stock |
| Jason Aryeh Director | Jun 10, 2026 | 500 | $124.98K | Jun 10, 2026 | Open Market Purchase |
| Kozarich John Director | May 13, 2026 | 1,575 | $352.01K | May 13, 2026 | Stock Option Exercise |
| Kozarich John Director | May 12, 2026 | 459 | $102.82K | May 12, 2026 | Stock Option Exercise |
| John W. Kozarich Director | May 1, 2026 | 467 | $107.35K | May 1, 2026 | Various |
| John W. Kozarich Director | Apr 1, 2026 | 467 | $95.03K | Apr 1, 2026 | Various |